Trilostane

Spécifications

13647-35-3Numéro CAS

237-133-0Numéro CE

(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrileNom IUPAC

C20H27NO3Formule chimique

329.4 g/molMasse molaire

Trilostane; 13647-35-3; Modrenal; Vetoryl; Desopan; Modrastane; Trilostano; Win-24540; Trilostanum; DTXSID9023706; WIN 24,540; L0FPV48Q5R; Win 24540; CHEBI:32260; NSC-758904; Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4alpha,5alpha,17beta)-; DTXCID103706; (1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.0^{2,8}.0^{6,8}.0^{12,16}]octadec-4-ene-4-carbonitrile; (1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo(9.7.0.0^(2,8).0^(6,8).0^(12,16))octadec-4-ene-4-carbonitrile; VETORYL CAPSULES; RefChem:56170; 4alpha,5-epoxy-17beta-hydroxy-3-oxoandrostane-2-carbonitrile; 2Alpha-cyano-4alpha,5alpha-epoxyandrostan-17beta-ol-3-one; (4Alpha,5alpha,17beta)-4,5-epoxy-3,17-dihydroxyandrost-2-ene-2-carbonitrile; 237-133-0; 4,5-Epoxy-17-hydroxy-3-oxoandrostane-2-carbonitrile; MFCD00199295; (1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile; 4alpha,5-Epoxy-3,17beta-dihydroxy-5alpha-androst-2-ene-2-carbonitrile; (1aR,4aR,4bS,6aS,7S,9aS,9bS,11aS)-2,7-dihydroxy-4a,6a-dimethyl-1a,4,4a,4b,5,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[1,10a-b]oxirene-3-carbonitrile; Modrenal (TN); Desopan (TN); CAS-13647-35-3; Trilostane (JAN/USAN); Trilostanum [INN-Latin]; Trilostano [INN-Spanish]; UNII-L0FPV48Q5R; (4alpha,5alpha,17beta)-3,17-dihydroxy-4,5-epoxyandrost-2-ene-2-carbonitrile; Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4.alpha.,5.alpha.,17.beta.)-; KVJXBPDAXMEYOA-CXANFOAXSA-N; Trilostane [USAN:INN:BAN:JAN]; NCGC00274061-01; EINECS 237-133-0; WIN 24450; Trilostane (Standard); TRILOSTANE [MI]; TRILOSTANE [INN]; TRILOSTANE [JAN]; TRILOSTANE [USAN]; TRILOSTANE [VANDF]; Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4a,5a,17b)-; SCHEMBL7517; TRILOSTANE [MART.]; TRILOSTANE [WHO-DD]; GTPL6850; orb1308537; Trilostane - Bio-X trade mark; TRILOSTANE [GREEN BOOK]; CHEMBL1200907; TRILOSTANE [ORANGE BOOK]; Trilostane, >=98% (HPLC); GLXC-06572; HMS3884A15; Tox21_112454; Tox21_302406; 4-alpha,5-Epoxy-3,17-dihydroxy-5-alpha-androst-2-ene-2-carbonitrile; AC-927; BDBM50247882; EBC-11126; HY-14281R; s1404; 3,17beta-dihydroxy-4alpha,5-epoxy-5alpha-androst-2-ene-2-carbonitrile; AKOS015964043; AKOS032947221; Tox21_112454_1; Trilostane(Win 24540; Modrastane)?; CCG-267803; CS-1707; DB01108; FT28510; KS-1414; NSC 758904; (2-alpha,4-alpha,5-alpha,17-beta)-4,5-Epoxy-17-hydroxy-3-oxoandrostane-2-carbonitrile; 4-alpha-5-Epoxy-17-beta-hydroxy-3-oxo-5-alpha-androstane-2-alpha-carbonitrile; Androstane-2-carbonitrile, 4,5-epoxy-17-hydroxy-3-oxo-, (2-alpha,4-alpha,5-alpha,17-beta)-; NCGC00255201-01; NCGC00274061-04; (1aR,4aR,4bS,6aS,7S,9aS,9bS,11aS)-2,7-dihydroxy-4a,6a-dimethyl-1a,4,4a,4b,5,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[1,10a-b]oxirene-3-carbonitrile.; BT300134; HY-14281; SY046020; NS00018304; D01180; EN300-122374; AB01274788-01; AB01274788_02; Q907313; Z1541759903; Trilostane; 13647-35-3; Vetoryl; Modrenal; Modrastane; 3,17beta-Dihydroxy-4alpha,5alpha-4,5-epoxyandrost-2-ene-2-carbonitrile; (2-alpha,4-alpha,5-alpha,17-beta)-4,5-epoxy-17-hydroxy-3-oxoandrostane-2-car; 5-alpha-ANDROSTANE-2-alpha-CARBONITRILE, 4-alpha,5-EPOXY-17-beta-HYDROXY-3-OXO-; Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4|A,5|A,17|A)-; (1S,2R,6R,8S,11S,12S,15S,16S)-2,16-dimethyl-5,15-bis(oxidanyl)-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrileSynonymes